Riskpilot← Back to searchSign inGet full accessElevera Sjukgymnaster AB
ABActiveOrg 5568326010Eriksbergsvägen 52Physiotherapy activities · NACE 8695Est. 20101 employees
Revenue 2024
SEK 1,1M
+5% vs 2023
EBITDA margin
16.0%
+91% vs 2023
Equity ratio
77.4%
Financial strength
Net profit 2024
SEK 136K
+394% vs 2023
| Revenue | SEK 1,1M | +5% |
| EBITDA | SEK 170K | +91% |
| Net profit | SEK 136K | +394% |
| Total assets | SEK 240K | +34% |
| Equity | SEK 186K | +69% |
| Employees | 1 | — |
Legal name
Elevera Sjukgymnaster AB
Org number
5568326010
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
14 december 2010
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva idrottsmedicinsk rehabiliteringsträning och ortopedisk manuell terapi i undersökning och behandling. Vi riktar oss mot patienter med skador och eller smärta i rörelse- och stödjeapparaten.
Address
Eriksbergsvägen 52
Email
info@elevera.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 890 | 876 | 779 | 1 006 | 1 057 |
| Staff expenses | — | — | −523 | −639 | −644 |
| EBITDA | 117 | 131 | 35 | 89 | 170 |
| Depreciation & amort. | −55 | −55 | −55 | −55 | −24 |
| EBIT | 62 | 76 | −19 | 34 | 146 |
| Net financials | — | −1 | −1 | 1 | 1 |
| Profit before tax | 61 | 76 | 2 | 35 | 172 |
| Tax | −13 | −16 | −1 | −7 | −36 |
| Net profit | 48 | 60 | 1 | 28 | 136 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 353 | 288 | 210 | 179 | 240 |
| Equity | 272 | 207 | 158 | 110 | 186 |
| Long-term debt | 0 | 0 | — | −0 | 0 |
| Short-term debt | 33 | 34 | 26 | 43 | 54 |
| Total debt | 33 | 34 | 26 | 43 | 54 |
EBITDA margin
16.0%
This company
15.8%
Market median
+1% vs market
20202024
Equity ratio
77.4%
This company
38.2%
Market median
+103% vs market
20202024
Return on equity
73.0%
This company
18.4%
Market median
+297% vs market
20202024
Net profit margin
12.9%
This company
8.1%
Market median
+59% vs market
20202024
Asset turnover
4.40×
This company
1.12×
Market median
+293% vs market
20202024
Debt / equity
0.29×
This company
0.62×
Market median
+53% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SO Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Elevera Sjukgymnaster AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sten Ola Lekselius | Chief Executive Officer | 0 companies |
| Tetti Kerstin R Lekselius Vallin | Deputy Board Member | 0 companies |
| Tetti Kerstin R Lekselius Vallin | Deputy Board Member | 0 companies |